Clozapine and Sweet's syndrome: case report

Abstract

A patient developed fever, raised inflammatory markers and a maculopapular rash following commencement of clozapine for treatment of his schizoaffective disorder. Skin biopsy confirmed Sweet's syndrome. Identification of the cause was challenging, with a number of possible considerations including infection, malignancy and various potential drug triggers.

Keywords

• Antipsychotics
• drug or substance interactions and side-effects
• in-patient treatment
• schizophrenia
• dermatology